Recently the US Food and Drug Administration issued a warning to several major device manufacturers about the marketing of vaginal rejuvenation devices. The notice clarified that the scope of FDA clearance on the machines only covered certain procedures, not including vaginal rejuvenation.

Jay Reyero, JD, partner at the law firm of ByrdAdatto weighs in on what this notice might mean for medical spa practices, and the steps owners and practitioners should take in light of the warning.

Share